Not applicableStudy completedNCT01015326
What this trial is testing
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
Who this might be right for
Skin Toxicities
Northwestern University 32